Yanagisawa, Takafumi
Mori, Keiichiro
Matsukawa, Akihiro
Kawada, Tatsushi
Katayama, Satoshi
Bekku, Kensuke
Laukhtina, Ekaterina
Rajwa, Pawel
Quhal, Fahad
Pradere, Benjamin
Fukuokaya, Wataru
Iwatani, Kosuke
Murakami, Masaya
Bensalah, Karim
Grünwald, Viktor
Schmidinger, Manuela
Shariat, Shahrokh F.
Kimura, Takahiro
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 26 October 2023
Accepted: 20 December 2023
First Online: 30 January 2024
Declarations
:
: Takahiro Kimura is a paid consultant/advisor for Astellas, Bayer, Janssen, and Sanofi. Shahrokh F. Shariat received honoraria from Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, and Takeda. Further, they are involved in a consulting or advisory role with Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, and Takeda and with the Speakers Bureau of Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, and Takeda. Manuela Schmidinger received honoraria for lectures to the advisory boards from Ipsen, Exelixis, BMS, MSD, Merck, EUSA, Eisai, Astellas, and Janssen. The other authors declare no conflicts of interest associated with this manuscript.